Literature DB >> 26058359

Claudin-4 controls the proliferation, apoptosis, migration and in vivo growth of MCF-7 breast cancer cells.

Xiaotang Ma1, Huilai Miao2, Baoguo Jing3, Qunwen Pan1, Huiting Zhang1, Yanfang Chen1, Dan Zhang3, Zhongzeng Liang2, Zhili Wen4, Mingyi Li2.   

Abstract

Previous studies have shown that the expression of claudin-4 is upregulated in breast cancer. The aim of the present study was to investigate the role and the regulation of claudin-4 in MCF-7 breast cancer cells. For the in vitro experiments, MCF-7 cells were treated with recombinant vectors carrying cDNA for claudin-4 overexpression or short hairpin RNAs (shRNAs) for claudin-4 silencing. Cell proliferation was determined by an MTT assay and cell migration ability was measured by a wound-healing assay. The cell cycle profile and apoptotic rate were analyzed using flow cytometry. The effect of methylation status on claudin-4 expression was determined by PCR and western blotting. For the in vivo tumorigenesis analysis, MCF-7 cells with or without claudin-4 silencing were transplanted into nude mice. In vivo cell growth was evaluated 14 days after transplantation. We found that claudin-4 overexpression increased MCF-7 cell proliferation and migration, and reduced the rate of cell apoptosis. Silencing of claudin-4 induced the opposite effects in MCF-7 cells. In addition, claudin-4 expression was upregulated by demethylation. Moreover, the size of tumor formation was reduced in nude mice transplanted with claudin-4 silenced MCF-7 cells. These observations suggested that claudin-4, which was regulated by methylation status, plays an important role in breast cancer growth and malignancy via the control of cell proliferation, migration and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26058359     DOI: 10.3892/or.2015.4037

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel.

Authors:  Christopher Breed; Douglas A Hicks; Patricia G Webb; Carly E Galimanis; Benjamin G Bitler; Kian Behbakht; Heidi K Baumgartner
Journal:  Mol Cancer Res       Date:  2019-01-03       Impact factor: 5.852

2.  Antiangiogenic effects of oridonin.

Authors:  Lili Tian; Kangjie Xie; Donglai Sheng; Xiaoqing Wan; Guofu Zhu
Journal:  BMC Complement Altern Med       Date:  2017-04-04       Impact factor: 3.659

3.  Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.

Authors:  Julia Baguña Torres; James C Knight; Michael J Mosley; Veerle Kersemans; Sofia Koustoulidou; Danny Allen; Paul Kinchesh; Sean Smart; Bart Cornelissen
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

4.  Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo.

Authors:  Haiyan Zhang; Beibei Xie; Zhen Zhang; Xiugui Sheng; Shiqian Zhang
Journal:  Drug Des Devel Ther       Date:  2018-12-20       Impact factor: 4.162

Review 5.  Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

Authors:  Ajaz A Bhat; Srijayaprakash Uppada; Iman W Achkar; Sheema Hashem; Santosh K Yadav; Muralitharan Shanmugakonar; Hamda A Al-Naemi; Mohammad Haris; Shahab Uddin
Journal:  Front Physiol       Date:  2019-01-23       Impact factor: 4.566

6.  Sox2 maintains epithelial cell proliferation in the successional dental lamina.

Authors:  Eun-Jung Kim; Seo-Yoon Jung; Zhaoming Wu; Sushan Zhang; Han-Sung Jung
Journal:  Cell Prolif       Date:  2019-11-19       Impact factor: 6.831

7.  Profiling the expression of pro-metastatic genes in association with the clinicopathological features of primary breast cancer.

Authors:  Seyed-Mohammad Mazloomi; Mitra Foroutan-Ghaznavi; Vahid Montazeri; Gholamreza Tavoosidana; Ashraf Fakhrjou; Hojjatollah Nozad-Charoudeh; Saeed Pirouzpanah
Journal:  Cancer Cell Int       Date:  2021-01-06       Impact factor: 5.722

8.  SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4/PI3K/AKT axis.

Authors:  Pengling Wang; Ting Liu; Zhendan Zhao; Zhiling Wang; Shujie Liu; Xingsheng Yang
Journal:  Cell Death Discov       Date:  2021-12-09

9.  TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation.

Authors:  Karolina Pospiech; Magdalena Orzechowska; Magdalena Nowakowska; Dorota Anusewicz; Elżbieta Płuciennik; Katarzyna Kośla; Andrzej K Bednarek
Journal:  J Appl Genet       Date:  2022-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.